MOLECULAR PARTNERS AG
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
other
SEC Category
Non-accelerated filerEmerging growth company
State of Incorporation
Switzerland
Business Address
WAGISTRASSE 14, Schlieren-Zurich, V8, 8952
Mailing Address
WAGISTRASSE 14, Schlieren-Zurich, V8, 8952
Phone
41 44 755 77 00
Fiscal Year End
1231
EIN
000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 6-K Foreign company current report | March 30, 2026 | View on SEC |
| 6-K Foreign company current report | March 13, 2026 | View on SEC |
| 6-K Foreign company current report | March 12, 2026 | View on SEC |
| 20-F Foreign company annual report | March 12, 2026 | View on SEC |
| 6-K Foreign company current report | February 2, 2026 | View on SEC |
| 6-K Foreign company current report | January 12, 2026 | View on SEC |
| 6-K Foreign company current report | December 8, 2025 | View on SEC |
| 6-K Foreign company current report | November 12, 2025 | View on SEC |
| 6-K Foreign company current report | October 30, 2025 | View on SEC |
| 6-K Foreign company current report | August 25, 2025 | View on SEC |
Annual Reports
20-F
March 12, 2026
- MOLECULAR PARTNERS AG leverages its proprietary DARPIN® technology for novel therapies, offering advantages over traditional antibodies.
- The company maintains significant co-development and license agreements with Novartis AG (focusing on DARPIN Conjugated Radioligand Therapies) and OranoMed.
Related Companies
Companies in the same industry (SIC: 2836)
Kodiak Sciences Inc.
KOD
Biological Products, (No Diagnostic Substances)
BioAtla, Inc.
BCAB
Biological Products, (No Diagnostic Substances)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
HALOZYME THERAPEUTICS, INC.
HALO
Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.